The Physician Payments Sunshine Act, which became law in 2010 as part of the Affordable Care Act, requires the Centers for Medicare & Medicaid Services (CMS) to collect and publicly report payments and other transfers of value to physicians and teaching hospitals by manufacturers of drugs, medical devices, and medical supplies. In this issue of JAMA Dermatology, Feng and colleagues1 report on more than $34 million paid in 2014 to dermatologists by industry sources that were made public under the Open Payments program. Consistent with findings from other specialties,2-6 they noted wide ranges in the magnitude of payments (the top 1% of recipients [n = 83] each received at least $93 622, while the median payment per dermatologist across all recipients was only $298), as well as payments distributed across multiple categories (eg, speaker fees, consulting, research, food and beverage, travel, and honoraria).1
Resneck JS. Transparency Associated With Interactions Between Industry and Physicians: Deficits in Accuracy and Consistency of Public Data Releases. JAMA Dermatol. 2016;152(12):1303–1304. doi:https://doi.org/10.1001/jamadermatol.2016.3279
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: